Nektar Therapeutics (NKTR)
0.9282
-0.01
(-1.36%)
USD |
NASDAQ |
Dec 20, 16:00
0.9213
-0.01
(-0.74%)
After-Hours: 20:00
Nektar Therapeutics Total Assets (Quarterly): 307.97M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 259.08M |
| Shareholders Equity (Quarterly) | 48.88M |
| Current Ratio | 4.239 |